A study published in Lancet Oncology by Dr. Iain McNeish (2016 Rivkin Pilot Award Recipient), Dr. Elizabeth Swisher (2009 Rivkin Pilot Award Recipient), and colleagues provided key data that helped fuel the FDA’s recent approval of rucaparib for ovarian cancers with defects in the BRCA1 and BRCA2 genes in women previously treated with two or more chemotherapies.
The Courage for Life Award was named in honor of Joe and Tyler White’s commitment to the Rivkin Center and the loving memory of Lori White and Mary Ellen Bissell, and recognizes those who, in the face of ovarian cancer, demonstrate a profound passion for life, a generosity to others, and an important contribution to […]
Long-term Rivkin Center partner, Skacel Collection, Inc. is launching a special promotion this September through their Makers Mercantile site! In honor of Ovarian Cancer Awareness Month and inspired by the Skacel family’s commitment to supporting ovarian cancer research, the company is offering a 10% discount off your ENTIRE purchase, which results in a 10% donation […]
Guest blogger Carol Reed shares the story of when she was diagnosed with ovarian cancer. Each woman’s ovarian cancer story is unique, and Carol emphasizes that she speaks only for herself. This is her experience.
Our 2016 SummeRun honoree has supported the event in almost every way possible—a survivor, a team captain, a fundraiser, and one of the top survivor finishers in last year’s run.
Jim Harting left the Rivkin Center the proceeds of the sale of his farm, and the $536,000 gift that Rivkin received this spring as a result of this bequest became one of the largest single gifts in our organization’s history.
Rita was in the middle of battling ovarian cancer and wanted to help others in a meaningful way. She donated a basket full of goodies she thought someone would enjoy.
The Rivkin Center kicked off the first of its 20th Anniversary celebrations this past week at our “Toast to 20” event. Friends of the Rivkin Center gathered to discuss the highlights of the past 20 years and our vision for the future of ovarian cancer research.
Dr. Saul E. Rivkin. I could almost stop there with this post, because Saul is a man who may be bigger than the words used to describe him. But he deserves more – much more.